News Detail
New York, 31 Oct 2022: An international team of researchers has identified a pan-variant and ultra-potent neutralising antibody that can offset Omicron variants.
Named 'S2X324', its neutralising potency was largely unaffected by any of the Omicron variants ......
View Details
Source : Business Standard
Immunology
Antibody
Glycoproteins
Omicron
O
Biology
Life sciences
Hospitals
Clinics & Primary Care Services
Biotechnology & Medical Research (NEC)
Switzerland
infection machinery
Washington University in St. Louis
vaccination
University of
Related News
- Researchers develop a better way to deliver long-lasting drugs (25-03-2025)
- Pioneer groundbreaking light-driven method to create key drug compounds (24-03-2025)
- Mandimycin: A polyene antifungal with a unique mode of action (22-03-2025)
- Newly identified bacterial protein helps design cancer drug delivery system (21-03-2025)
- IIT Roorkee researchers identify a potential drug against Chikungunya (18-03-2025)
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)